Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120378149> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W3120378149 endingPage "S36" @default.
- W3120378149 startingPage "S35" @default.
- W3120378149 abstract "BM occur in 20–40% of NSCLC harboring METex14 skipping. We investigated the activity of the MET inhibitor tepotinib in BM in preclinical models and patients from the VISION study (NCT02864992). Penetration of the blood–brain barrier was assessed in Wistar rats (n=3) at 3.66 mg/kg/h intravenous tepotinib by determining the unbound brain (fu br)-to-plasma (fu pl) concentration or exposure ratio (Kp u,u). Efficacy was assessed in two lung cancer patient-derived xenografts (PDXs) from BM harboring high MET amplification (gain in copy number: LU5349 = 11, LU5406 = 24) grown in NOD-SCID mice. Subcutaneous PDXs (n=5/group) or PDXs orthotopically implanted into the brain (n=10/group) were treated with tepotinib 125 mg/kg or vehicle control orally once daily. Intracranial tumor growth was monitored by gadolinium-based MRI. In VISION Cohort A, patients with METex14 skipping NSCLC received tepotinib 500 mg once daily. Systemic objective response per RECIST v1.1 by independent review committee (IRC) was a preplanned analysis in patients with baseline BM identified by IRC (BM-IRC) or investigator assessment (BM-INV). Preclinical data indicated high binding of tepotinib in the brain, with unbound tepotinib in brain tissue being lower than in plasma (fu br = 0.4%, fu pl = 4%). Unbound tepotinib concentrations in the brain were 25% of plasma (Kp u,u = 0.25). Tepotinib treatment resulted in tumor regression in both PDXs (mean % tumor volume: –84% in LU5349, –63% in LU5406). As of 1 Jan 2020, 22/152 patients enrolled in Cohort A had baseline BM, with similar characteristics and comparable systemic response data (table) to the overall population. Tepotinib administration resulted in tumor regression in MET-driven lung cancer BM PDX models. Clinical activity in patients with NSCLC harboring METex14 skipping with baseline BM was consistent with the overall population in VISION. Cohort C aims to assess intracranial response. Previously presented at ESMO Congress 2020, “FNP:1286P”, “Santiago Viteri et al.” - Reused with permission" @default.
- W3120378149 created "2021-01-18" @default.
- W3120378149 creator A5000703352 @default.
- W3120378149 creator A5001058762 @default.
- W3120378149 creator A5003664573 @default.
- W3120378149 creator A5007462622 @default.
- W3120378149 creator A5010446846 @default.
- W3120378149 creator A5021088641 @default.
- W3120378149 creator A5029413426 @default.
- W3120378149 creator A5036477513 @default.
- W3120378149 creator A5040541281 @default.
- W3120378149 creator A5040589443 @default.
- W3120378149 creator A5055246540 @default.
- W3120378149 creator A5055627152 @default.
- W3120378149 creator A5065197387 @default.
- W3120378149 creator A5066701277 @default.
- W3120378149 creator A5070125088 @default.
- W3120378149 creator A5077467021 @default.
- W3120378149 creator A5086379942 @default.
- W3120378149 creator A5090324173 @default.
- W3120378149 date "2021-01-01" @default.
- W3120378149 modified "2023-09-26" @default.
- W3120378149 title "MO01.46 Tepotinib Activity in Brain Metastases (BM): Preclinical Models and Clinical Data from MET Exon 14 (METex14) Skipping NSCLC" @default.
- W3120378149 doi "https://doi.org/10.1016/j.jtho.2020.10.150" @default.
- W3120378149 hasPublicationYear "2021" @default.
- W3120378149 type Work @default.
- W3120378149 sameAs 3120378149 @default.
- W3120378149 citedByCount "0" @default.
- W3120378149 crossrefType "journal-article" @default.
- W3120378149 hasAuthorship W3120378149A5000703352 @default.
- W3120378149 hasAuthorship W3120378149A5001058762 @default.
- W3120378149 hasAuthorship W3120378149A5003664573 @default.
- W3120378149 hasAuthorship W3120378149A5007462622 @default.
- W3120378149 hasAuthorship W3120378149A5010446846 @default.
- W3120378149 hasAuthorship W3120378149A5021088641 @default.
- W3120378149 hasAuthorship W3120378149A5029413426 @default.
- W3120378149 hasAuthorship W3120378149A5036477513 @default.
- W3120378149 hasAuthorship W3120378149A5040541281 @default.
- W3120378149 hasAuthorship W3120378149A5040589443 @default.
- W3120378149 hasAuthorship W3120378149A5055246540 @default.
- W3120378149 hasAuthorship W3120378149A5055627152 @default.
- W3120378149 hasAuthorship W3120378149A5065197387 @default.
- W3120378149 hasAuthorship W3120378149A5066701277 @default.
- W3120378149 hasAuthorship W3120378149A5070125088 @default.
- W3120378149 hasAuthorship W3120378149A5077467021 @default.
- W3120378149 hasAuthorship W3120378149A5086379942 @default.
- W3120378149 hasAuthorship W3120378149A5090324173 @default.
- W3120378149 hasBestOaLocation W31203781491 @default.
- W3120378149 hasConcept C126322002 @default.
- W3120378149 hasConcept C143998085 @default.
- W3120378149 hasConcept C2779984678 @default.
- W3120378149 hasConcept C31760486 @default.
- W3120378149 hasConcept C535046627 @default.
- W3120378149 hasConcept C71924100 @default.
- W3120378149 hasConcept C72563966 @default.
- W3120378149 hasConceptScore W3120378149C126322002 @default.
- W3120378149 hasConceptScore W3120378149C143998085 @default.
- W3120378149 hasConceptScore W3120378149C2779984678 @default.
- W3120378149 hasConceptScore W3120378149C31760486 @default.
- W3120378149 hasConceptScore W3120378149C535046627 @default.
- W3120378149 hasConceptScore W3120378149C71924100 @default.
- W3120378149 hasConceptScore W3120378149C72563966 @default.
- W3120378149 hasIssue "1" @default.
- W3120378149 hasLocation W31203781491 @default.
- W3120378149 hasOpenAccess W3120378149 @default.
- W3120378149 hasPrimaryLocation W31203781491 @default.
- W3120378149 hasRelatedWork W2035682242 @default.
- W3120378149 hasRelatedWork W2071535500 @default.
- W3120378149 hasRelatedWork W2076975930 @default.
- W3120378149 hasRelatedWork W2101737224 @default.
- W3120378149 hasRelatedWork W2315085516 @default.
- W3120378149 hasRelatedWork W2316316929 @default.
- W3120378149 hasRelatedWork W2603773853 @default.
- W3120378149 hasRelatedWork W2952239533 @default.
- W3120378149 hasRelatedWork W2964295425 @default.
- W3120378149 hasRelatedWork W2999832097 @default.
- W3120378149 hasVolume "16" @default.
- W3120378149 isParatext "false" @default.
- W3120378149 isRetracted "false" @default.
- W3120378149 magId "3120378149" @default.
- W3120378149 workType "article" @default.